ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,235Medicare Part D Prescriptions Filled, Including Refills

Rank: 535 out of 2170

$438K Total Retail Price of All Prescriptions

Rank: 580 out of 2170

320 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,212 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 350 267 1 2
LEVOTHYROXINE SODIUM 333 282 2 5
SIMVASTATIN 282 249 3 1
AMLODIPINE BESYLATE 267 223 4 4
LISINOPRIL 231 179 5 3
METFORMIN HCL 205 181 6 8
CRESTOR 171 110 7 24
GABAPENTIN 163 93 8 14
WARFARIN SODIUM 159 105 9 15
CITALOPRAM HBR 156 127 10 19
FUROSEMIDE 150 121 11 6
ATENOLOL 147 114 12 23
HYDROCHLOROTHIAZIDE 137 116 13 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 114 14 20
SYNTHROID 126 124 15 27
HYDROCODONE-ACETAMINOPHEN 126 84 S3 15 7
ATORVASTATIN CALCIUM 126 103 15 12
LOVASTATIN 125 100 18 34
FLUTICASONE PROPIONATE 109 83 19 30
PRAVASTATIN SODIUM 106 74 20 11
SERTRALINE HCL 103 85 21 25
METOPROLOL TARTRATE 97 69 22 10
ZOLPIDEM TARTRATE 87 44 23 17
LOSARTAN POTASSIUM 84 75 24 21
NEXIUM 81 50 25 22
AZITHROMYCIN 76 56 26 47
POTASSIUM CHLORIDE 75 64 27 16
TRAMADOL HCL 71 68 28 18
GLIPIZIDE 70 60 29 62
PREDNISONE 69 52 30 41
GEMFIBROZIL 68 52 31 121
DIOVAN HCT 66 54 32 76
RANITIDINE HCL 65 39 33 40
METOPROLOL SUCCINATE 64 52 34 13
ALLOPURINOL 62 57 35 29
ALENDRONATE SODIUM 61 35 36 36
COMBIVENT 61 47 36 112
POLYETHYLENE GLYCOL 3350 56 30 38 63
ESCITALOPRAM OXALATE 56 31 38 75
CYCLOBENZAPRINE HCL 54 40 R 40 52
DILTIAZEM 24HR ER 53 53 41 135
GLIPIZIDE XL 53 29 41 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.